Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medtronic Claims Share Gains In Cardiovascular And Neurostim

Executive Summary

The company’s revenue was down just 1% year-over-year in the third quarter of fiscal 2021, despite the ongoing impact of the pandemic.

You may also be interested in...



Market Intel: Rivalry Among Insulin Pump Makers Heats Up With Expected Launches In 2021

The global insulin pump market is expected to see double-digit growth, reaching $5.1bn in 2024, with product launches expected by Medtronic, Insulet, Tandem and smaller players in 2021. 

Boston Scientific Is Counting On COVID-19 Vaccine To Rebound In 2021

The company expects revenues across its businesses to rapidly return to their pre-pandemic growth rates in the second half of 2021.

Medtronic Brings Radial Access Technology To Brain Interventions

The company has begun a limited release of the radial artery access devices it added to its neurovascular therapies business when it quietly acquired RIST Neurovascular in 2020.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

MT143549

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel